{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:33:32Z","timestamp":1774355612507,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.5664\/jcsm.2048","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T16:33:57Z","timestamp":1344962037000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Sodium Oxybate for Narcolepsy with Cataplexy: Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"8","author":[{"given":"Mashael K.","family":"Alshaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea C.","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Tashkandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon E.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"BaHammam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"BF0804017_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","volume":"369","author":"Y Dauvilliers","year":"2007","unstructured":"Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499\u2013511.","journal-title":"Lancet"},{"key":"BF0804017_CR2","first-page":"1352","volume":"27","author":"AS BaHammam","year":"2006","unstructured":"BaHammam AS, Alenezi AM. Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder. Saudi Med J 2006;27:1352\u20137.","journal-title":"Saudi Med J"},{"key":"BF0804017_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","volume":"25","author":"MH Silber","year":"2002","unstructured":"Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002;25:197\u2013202.","journal-title":"Sleep"},{"key":"BF0804017_CR4","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S1388-2457(03)00203-7","volume":"114","author":"Y Dauvilliers","year":"2003","unstructured":"Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003;114:2000\u201317.","journal-title":"Clin Neurophysiol"},{"key":"BF0804017_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","volume":"30","author":"WT Longstreth Jr","year":"2007","unstructured":"Longstreth WTJr Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007;30:13\u201326.","journal-title":"Sleep"},{"key":"BF0804017_CR6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1517\/14656566.2010.484021","volume":"11","author":"M Zaharna","year":"2010","unstructured":"Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother 2010;11:1633\u201345.","journal-title":"Expert Opin Pharmacother"},{"key":"BF0804017_CR7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/WCO.0b013e3282f22ad9","volume":"20","author":"S Keam","year":"2007","unstructured":"Keam S, Walker MC. Therapies for narcolepsy with or without cataplexy: evidence-based review. Curr Opin Neurol 2007;20:699\u2013703.","journal-title":"Curr Opin Neurol"},{"key":"BF0804017_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 1997;51:337\u201361.","journal-title":"Prog Neurobiol"},{"key":"BF0804017_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)37787-0","volume":"287","author":"TE Madden","year":"1998","unstructured":"Madden TE, Johnson SW. Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther 1998;287:261\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF0804017_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dot.2008.44.3.1162240","volume":"44","author":"RT Owen","year":"2008","unstructured":"Owen RT. Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy. Drugs Today (Barc) 2008;44:197\u2013204.","journal-title":"Drugs Today (Barc)"},{"key":"BF0804017_CR11","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.","journal-title":"BMJ"},{"key":"BF0804017_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","volume":"28","author":"MR Littner","year":"2005","unstructured":"Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113\u201321.","journal-title":"Sleep"},{"key":"BF0804017_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0013-4694(95)00075-A","volume":"95","author":"RD Chervin","year":"1995","unstructured":"Chervin RD, Kraemer HC, Guilleminault C. Correlates of sleep latency on the multiple sleep latency test in a clinical population. Electroencephalogr Clin Neurophysiol 1995;95:147\u201353.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"BF0804017_CR14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540\u20135.","journal-title":"Sleep"},{"key":"BF0804017_CR15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"BF0804017_CR16","doi-asserted-by":"crossref","first-page":"b4012","DOI":"10.1136\/bmj.b4012","volume":"339","author":"L Hartling","year":"2009","unstructured":"Hartling L, Ospina M, Liang Y, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009;339:b4012.","journal-title":"BMJ"},{"key":"BF0804017_CR17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046\u201355.","journal-title":"J Clin Epidemiol"},{"key":"BF0804017_CR18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"BF0804017_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"BF0804017_CR20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","volume":"1","author":"Xyrem International Study Group","year":"2005","unstructured":"Xyrem International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391\u20137.","journal-title":"J Clin Sleep Med"},{"key":"BF0804017_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.sleep.2003.11.002","volume":"5","author":"U.S. Xyrem Multicenter Study Group","year":"2004","unstructured":"U.S. Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med 2004;5:119\u201323.","journal-title":"Sleep Med"},{"key":"BF0804017_CR22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","volume":"29","author":"J Black","year":"2006","unstructured":"Black J, Houghton WC. Sodium oxybate improves excessive daytime sleepiness in narcolepsy. Sleep 2006;29:939\u201346.","journal-title":"Sleep"},{"key":"BF0804017_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/sleep\/25.8.42","volume":"25","author":"The U.S. Xyrem Multicenter Study Group","year":"2002","unstructured":"The U.S. Xyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42\u20139.","journal-title":"Sleep"},{"key":"BF0804017_CR24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/sleep\/16.3.216","volume":"16","author":"GJ Lammers","year":"1993","unstructured":"Lammers GJ, Arends J, Declerck AC, Ferrari MD, Schouwink G, Troost J. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep 1993;16:216\u201320.","journal-title":"Sleep"},{"key":"BF0804017_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-3223(89)90048-6","volume":"26","author":"L Scrima","year":"1989","unstructured":"Scrima L, Hartman PG, Johnson FHJr Hiller FC. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures. Biol Psychiatry 1989;26:331\u201343.","journal-title":"Biol Psychiatry"},{"key":"BF0804017_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.sleep.2005.03.010","volume":"6","author":"Xyrem International Study Group","year":"2005","unstructured":"Xyrem International Study Group. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients. Sleep Med 2005;6:415\u201321.","journal-title":"Sleep Med"},{"key":"BF0804017_CR27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/sleep\/29.9.1189","volume":"29","author":"TE Weaver","year":"2006","unstructured":"Weaver TE, Cuellar N. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006;29:1189\u201394.","journal-title":"Sleep"},{"key":"BF0804017_CR28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.sleep.2009.05.004","volume":"10","author":"J Black","year":"2009","unstructured":"Black J, Pardi D, Hornfeldt CS, Inhaber N. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Sleep Med 2009;10:829\u201335.","journal-title":"Sleep Med"},{"key":"BF0804017_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0091270003262795","volume":"44","author":"LA Borgen","year":"2004","unstructured":"Borgen LA, Okerholm RA, Lai A, Scharf MB. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 2004;44:253\u20137.","journal-title":"J Clin Pharmacol"},{"key":"BF0804017_CR30","unstructured":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003;26:31\u20135."},{"key":"BF0804017_CR31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.sleep.2008.04.004","volume":"10","author":"RK Ristanovic","year":"2009","unstructured":"Ristanovic RK, Liang H, Hornfeldt CS, Lai C. Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy. Sleep Med 2009;10:416\u201321.","journal-title":"Sleep Med"},{"key":"BF0804017_CR32","doi-asserted-by":"crossref","unstructured":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. J Clin Sleep Med 2005;1:391\u20137.","DOI":"10.5664\/jcsm.26368"},{"key":"BF0804017_CR33","first-page":"RA177","volume":"16","author":"D Golicki","year":"2010","unstructured":"Golicki D, Bala MM, Niewada M, Wierzbicka A. Modafinil for narcolepsy: systematic review and meta-analysis. Med Sci Monit 2010;16:RA177\u201386.","journal-title":"Med Sci Monit"},{"key":"BF0804017_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0b013e318203d415","volume":"34","author":"MK Alshaikh","year":"2011","unstructured":"Alshaikh MK, Gacuan D, George S, Sharif M, Bahammam AS. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem). Clin Neuropharmacol 2011;34:1\u20134.","journal-title":"Clin Neuropharmacol"},{"issue":"1 Pt 2","key":"BF0804017_CR35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/sleep\/9.1.232","volume":"9","author":"TL Baker","year":"1986","unstructured":"Baker TL, Guilleminault C, Nino-Murcia G, Dement WC. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep 1986;9(1 Pt 2):232\u201342.","journal-title":"Sleep"},{"key":"BF0804017_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100119304","volume":"6","author":"R Broughton","year":"1979","unstructured":"Broughton R, Mamelak M. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 1979;6:1\u20136.","journal-title":"Can J Neurol Sci"},{"key":"BF0804017_CR37","first-page":"23","volume":"7","author":"R Broughton","year":"1980","unstructured":"Broughton R, Mamelak M. Effects of nocturnal gamma-hydroxybutyrate on sleep\/waking patterns in narcolepsy-cataplexy. Can J Neurol Sci 1980;7:23\u201331.","journal-title":"Can J Neurol Sci"},{"key":"BF0804017_CR38","first-page":"222","volume":"46","author":"MB Scharf","year":"1985","unstructured":"Scharf MB, Brown D, Woods M, Brown L, Hirschowitz J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985;46:222\u20135.","journal-title":"J Clin Psychiatry"},{"key":"BF0804017_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/sleep\/13.6.479","volume":"13","author":"L Scrima","year":"1990","unstructured":"Scrima L, Hartman PG, Johnson FHJr Thomas EE, Hiller FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep 1990;13:479\u201390.","journal-title":"Sleep"},{"key":"BF0804017_CR40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/sleep\/27.7.1327","volume":"27","author":"M Mamelak","year":"2004","unstructured":"Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27:1327\u201334.","journal-title":"Sleep"},{"key":"BF0804017_CR41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5664\/jcsm.27994","volume":"6","author":"J Black","year":"2010","unstructured":"Black J, Pardi D, Hornfeldt CS, Inhaber N. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy. J Clin Sleep Med 2010;6:596\u2013602.","journal-title":"J Clin Sleep Med"},{"key":"BF0804017_CR42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00023210-200721040-00007","volume":"21","author":"DM Robinson","year":"2007","unstructured":"Robinson DM, Keating GM. Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs 2007;21:337\u201354.","journal-title":"CNS Drugs"},{"key":"BF0804017_CR43","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","volume":"30","author":"TI Morgenthaler","year":"2007","unstructured":"Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:1705\u201311.","journal-title":"Sleep"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.2048\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.aasmnet.org\/jcsm\/viewabstract.aspx?pid=28622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.5664\/jcsm.2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:05:39Z","timestamp":1770365139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.5664\/jcsm.2048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8,15]]}},"alternative-id":["BF0804017"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.2048","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]},"assertion":[{"value":"1 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}